Conmed Corp CNMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
CONMED Corporation Announces Preliminary Third Quarter Financial Information
-
CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference
-
CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare Conference
-
CONMED Corporation Announces Quarterly Cash Dividend
-
CONMED Corporation Announces Second Quarter 2024 Financial Results
-
CONMED Corporation to Announce Second Quarter 2024 Financial Results on July 31, 2024
Trading Information
- Previous Close Price
- $66.56
- Day Range
- $65.97–69.81
- 52-Week Range
- $61.05–117.27
- Bid/Ask
- $64.68 / $80.58
- Market Cap
- $2.05 Bil
- Volume/Avg
- 461,560 / 425,913
Key Statistics
- Price/Earnings (Normalized)
- 17.85
- Price/Sales
- 1.64
- Dividend Yield (Trailing)
- 1.20%
- Dividend Yield (Forward)
- 1.20%
- Total Yield
- 1.20%
Company Profile
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 4,000
- Website
- https://www.conmed.com
Comparables
Valuation
|
Metric
|
CNMD
|
688016
|
002901
|
|---|---|---|---|
Price/Earnings (Normalized) | 17.85 | 22.39 | 907.94 |
Price/Book Value | 2.33 | 3.46 | 4.23 |
Price/Sales | 1.64 | 9.68 | 7.61 |
Price/Cash Flow | 11.33 | 19.38 | 35.09 |
Price/Earnings
CNMD
688016
002901
Financial Strength
|
Metric
|
CNMD
|
688016
|
002901
|
|---|---|---|---|
Quick Ratio | 1.01 | 8.91 | 1.68 |
Current Ratio | 2.34 | 9.53 | 2.95 |
Interest Coverage | 4.20 | 413.50 | 13.19 |
Quick Ratio
CNMD
688016
002901
Profitability
|
Metric
|
CNMD
|
688016
|
002901
|
|---|---|---|---|
Return on Assets (Normalized) | 5.07% | 16.12% | 1.51% |
Return on Equity (Normalized) | 14.10% | 18.19% | 2.20% |
Return on Invested Capital (Normalized) | 8.09% | 17.54% | 1.37% |
Return on Assets
CNMD
688016
002901
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Jsxdpbm | Kyqkfl | $196.0 Bil | |||
| Stryker Corp
SYK
| Frxbtvvl | Xnmbz | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Xjghzvkm | Nyhlpd | $124.5 Bil | |||
| Medtronic PLC
MDT
| Srflfjwd | Qswjz | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Qqbkcwzvz | Hhpvdf | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Ccsys | Fkvl | $30.2 Bil | |||
| DexCom Inc
DXCM
| Mgtlcmcnr | Znqj | $27.3 Bil | |||
| Steris PLC
STE
| Mhqmzyq | Cgklrw | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Cvmynwvf | Qhg | $21.3 Bil | |||
| Insulet Corp
PODD
| Jtvwgtdfd | Pbwdw | $16.1 Bil |
United States